Analysis of drugs and personal care products in French source and drinking waters: The analytical challenge and examples of application

Water Science and Technology

Volumn 52, Issue 8, 2005, Pages 53-61

  Bruchet, Auguste ^a   Hochereau, C ^a   Picard, C ^a   Decottignies, V ^a   Rodrigues, J M ^a   Janex Habibi, M L ^a  

^a CIRSEE   (France)

Author keywords

Antibiotics; Drugs; Musks; Surface waters; X ray contrast media

Indexed keywords

ANTIBIOTICS; BIODEGRADATION; CONTRAST MEDIA; DRUG PRODUCTS; HAZARDOUS MATERIALS SPILLS; POTABLE WATER; RIVERS; SURFACE WATER RESOURCES; WATER QUALITY;

ANTIBIOTIC ROXITHROMYCIN; ANTIBIOTIC SULFAMETHOXAZOLE; CHEMICAL SPILL; DRINKING WATER TREATMENT; MUSKS; PERSONAL CARE PRODUCTS; X-RAY CONTRAST MEDIA;

WATER TREATMENT;

CARBAMAZEPINE; DIAZEPAM; DRINKING WATER; FRAGRANCE; GALAXOLIDE; GROUND WATER; IBUPROFEN; IOPROMIDE; ROXITHROMYCIN; SULFAMETHOXAZOLE; SURFACE WATER; TONALIDE; TRANQUILIZER; UNCLASSIFIED DRUG;

DRINKING WATER;

ADSORPTION; ARTICLE; DERIVATIZATION; DRUG IDENTIFICATION; FILTRATION; FRANCE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHYLATION; NONHUMAN; OZONATION; SILYLATION; SOLID PHASE EXTRACTION; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WATER ANALYSIS; WATER CONTAMINATION; WATER QUALITY; WATER SUPPLY; WATER TREATMENT;

EID: 28444457681     PISSN: 02731223     EISSN: None     Source Type: Journal    
DOI: 10.2166/wst.2005.0224     Document Type: Article

References (12)

1. Circulaire DGS/SD7A no 2003/445, 17 September 2003.
2. Clara, M., Strenn, B. and Kreuzinger, N. (2004). Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Research, 38, 947-954.
3. Daughton, C.G. and Ternes, T.A. (1999). Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ. Health Perspect., 107(6), 907-938.
4. Directive 2000/60/CE. Journal Officiel des Communautés Européennes, 22.12.2000, L327-73.
5. Janex, M.L., Bruchet, A., Charles, P., Huber, M. and Ternes, T. (2003). Assessment of advanced drinking water treatment processes for endocrine disrupting compounds and pharmaceuticals removal. IWA Leading Edge Conference, Noordwijk/Amsterdam, May 26-28, 2003. Proceedings p. 29.
6. Heberer, T. and Stan, H.J. (1996). Vorkommen von polaren organischen Kontaminenten im Berliner Trinkwasser. Im Wasser, 86, 19-31.
7. Heberer, T., Dünnbier, U., Reilich, C. and Stan, H.-J. (1997). Detection of drugs and drug metabolites in ground water samples of a drinking water treatment plant. Fresenius Environ. Bull., 6, 438-443.
8. Mons, M.N., Hogenboom, A.C. and Noij, T.H.M (2003) Pharmaceuticals and drinking water supply in The Netherlands. Kiwa report no. BTO 2003.040, Kiwa Water Research, Nieuwegein, The Netherlands.
9. Sacher, F., Lange, F.T., Branch, H. J. and Blankenhorn, I. (2001) Pharmaceuticals in groundwaters. Analytical methods and results of a monitoring program in Baden-Wrttemberg, Germany.
10. Ternes, T.A. (2001). Pharmaceuticals and metabolites as contaminants of the aquatic environment. In Pharmaceuticals and Personal Care Products in the Environment. Scientific and Regulatory Issues, Daughton, C.G. and Jones-Lepp, T.L. (eds.), ACS Symposium series 791.
11. Vanderford, B.J., Pearson, R.A., Rexing, D.J. and Snyder, S.A. (2003). Analysis of endocrine disruptors, pharmaceuticals and personal care products in water using liquid chromatography/tandem mass spectrometry. Analytical Chemistry, 75, 6265-6274.
12. Versteegh, J.F.M., Stolker, A.A.M., Niesing, W. and Muller, J.J.A. (2003). Geneesmiddelen in drinkwater en drinkwaterbronnen. RIVM-report nr.703719004/2003, RIVM, Bilthoven, The Netherlands.